Removal of non-transferrin-bound iron from blood with iron overload using a device with immobilized desferrioxamine

Journal of Medicine

Volumn 30, Issue 3-4, 1999, Pages 211-224

  Ambrus, Clara M ^a,b,c   Stadler, Istvan ^b   Toumbis, Constantine A ^b   Stadler, Agnes ^c   Anthone, Sidney ^a   Anthone, Roland ^a   DeAlarcon, Pedro ^a   Deshpande, Ganesh ^a   Conway, James ^a   Vladutiu, Adrian O ^a   Ambrus Jr , Julian L ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Chelation process; Immobilized desferrioxamine; Iron overload; Non transferrin bound iron

Indexed keywords

DEFEROXAMINE; IRON; IRON BINDING PROTEIN; TRANSFERRIN;

ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; EXTRACORPOREAL CIRCULATION; FIBER; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IRON BINDING CAPACITY; IRON CHELATION; IRON KINETICS; IRON OVERLOAD; SICKLE CELL ANEMIA;

ANEMIA; BLOOD TRANSFUSION; CHEMICAL FRACTIONATION; CHILD; CHROMATOGRAPHY, GEL; DEFEROXAMINE; HEMOCHROMATOSIS; HUMANS; IRON; IRON CHELATING AGENTS; IRON OVERLOAD; TRANSFERRIN;

EID: 6744236251     PISSN: 00257850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Adelman, T.G., Arosio, P. and Drysdate, J.W. (1975).: Multiple subunits in human ferritins: evidence for hybrid molecules. Biochem. Biophys. Res. Comm. 63: 1056.
2. Ambrus, C.M., Anthone, S., Deshpande, G., Horwath, C.S. and Kalghatgi, K. (1987).: Extracorporeal removal of iron with immobilized desferrioxamine. Trans. ASAIO 10: 749.
3. Anthone, S., Ambrus, C.M., Kohli, R.K., Min, I., Anthone, R., Stadler, A., Stadler, I. and Vladutiu, A. (1995).: Treatment of aluminum overload using a cartridge with immobilized desferrioxamine. J. Amer. Soc. Nephrol. 6: 1271-1277.
4. Boelaert, J.R., Fenves, A.Z. and Coburn, J.W. (1991).: Deferoxamine therapy and mucormycosis in dialysis patients: Reports of an international registry. Amer. J. Kidney Dis. 18: 660.
5. Bridges K.R. (1990).: Modulation of the availability of intracellular iron. In: Iron Transport and Storage. Edited by P. Ponka, H.M. Schulman, R.C. Woodworth. CRC Press. Boca Raton, FL. p. 305.
6. Brittenham, G.M. (1992).: Development of iron-chelating agents for clinical use. Blood 80: 569.
7. Cohen, A.R., Martin, M.B., Silber, J.H., Kim. H.C., Ohene-Frempong, K. and Schwartz, E. (1992).: A modified transfusion program for prevention of stroke in sickle cell disease. Blood 79: 1675.
8. Cross, C.E., Halliwell, B., Borish, E.T., Pryor, W.A., Ames, B., Saul, R.L., McCord, T.M. and Harmon, D. (1987).: Oxygen radicals and human disease. Ann. Int. Med. 107: 526.
9. Fosburg, M.T. and Nathan, D.G. (1990).: Treatment of Cooleys Anemia. Blood 76:435.
10. Gutteridge, J.M.C., Rowley, D.A, and Halliwell, B. (1982).: Superoxide dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Biochem. J, 206: 605.
11. Halliday, J.W. and Powell, L.W. (1992).: Hemochromatosis and other diseases associated with iron overload. In: Iron and Human Disease. Edited by R.B. Lauffer. CRC Press. Boca Raton, FL. p. 131.
12. Harrison, P.M., Hoy, T.G., Macara, J.G. and Hoare, R.J. (1974).: Ferritin iron uptake and release. Structure-function relationship. Biochem. J. 143: 445.
13. Hershko, C., Graham, G., Bates, G.W. and Rachmilewitz, E.A. (1978).: Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity. Brit. J. Haematol. 40: 255.
14. Hershko, C. and Peto, T.E.A. (1987).: Non-transferrin plasma iron. Brit. J. Haematol. 206: 149.
15. Jacobs, A. (1977).: Low molecular weight intracellular iron transport compounds. Blood 50: 433.
16. Jacobs, D.M., Julsrud, J.M. and Bubrick, M.P. (1991).: Iron chelation with desferrioxamine conjugate in hemorrhagic shock, J. Surg. Res. 51: 484.
17. O'Connell, M.J., Ward, R.J., Baum, H. and Peters, T.J. (1989).: Iron release from hemosiderin and ferritin by therapeutic and physiological chelators. Biochem. J. 260: 903-907.
18. Olivieri, N.F., Raymond-Buncic, J. and Chew, E. (1986).: Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N. Engl. J. Med. 314: 869.
19. Pippard, M.J. (1987).: Iron overload and iron chelation therapy in Thalassemia and sickle cell hemoglobinopathies, Acta Haematol. 78: 206.
20. Polson, R.J., Jawed, A., Bomford A., Berry, H. and Williams, R. (1985).: Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects. Brit. Med. J. 291:448.
21. Salonen, T.J., Nyyssonen, K., Korpela, H., Tuomilehto, J., Sappeanen, R. and Salonen, E. (1992).: High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 86: 803.
22. Tenenbein, M., Kowanski, W., Sienko, A., Bowden, D.H. and Adamson, I.Y.R. (1992).: Pulmonary toxic effects of continuous desferrioxamine administration in acute iron poisoning. Lancet 339: 699.
23. Trenam, C.W., Winyard, P.G., Morris, C.J., Blake, D.R. (1992).: Iron-promoted oxidative damage in rheumatic diseases. In: Iron and Human Disease. Edited by R.B. Lauffer. CRC Press. Boca Raton, FL. p. 395.
24. Wang, W.C., Ahmed, N. and Hanna, M. (1986).: Non-transferrin bound iron in long term transfusion in children with congenital anemias. J. Pediatr. 108: 552.
25. Zweier, J.L. (1992).: The role of iron in myocardial reperfusion injury. In: Iron and Human Disease. Edited by R.B. Lauffer. CRC Press. Boca Raton, FL. p. 271.